首页> 美国卫生研究院文献>Vaccines >Immunization Status against Measles Mumps Rubella and Varicella in a Large Population of Internationally Adopted Children Referred to Meyer Children’s University Hospital from 2009 to 2018
【2h】

Immunization Status against Measles Mumps Rubella and Varicella in a Large Population of Internationally Adopted Children Referred to Meyer Children’s University Hospital from 2009 to 2018

机译:2009年至2018年在迈耶儿童大学医院转诊的大量国际收养儿童中针对麻疹腮腺炎风疹和水痘的免疫状况

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Control of vaccine preventable diseases (VPDs) is a challenge for healthcare systems. Different studies highlighted the suboptimal immunization of internationally adopted children (IAC). To evaluate the immunization status against measles, mumps, rubella (MMR), and varicella (V) in a large cohort of IAC, data at first screening visit of all IAC (<18 years) consecutively referred to Meyer Children’s University Hospital (Florence, Italy) from 2009 to 2018 were collected and analyzed. In total, 1927 children (median age: 5.99 years, interquartile range: 3.33–8.21) were enrolled. More than half of IAC were unprotected against MMR-V. The reliability of the vaccination documentation of the country of origin was poor, since more than a quarter of the IAC serologically tested were not protected against MMR-V, despite the vaccination documentation attesting previous vaccination. This was significantly more pronounced in children aged 15–18 years and in those originating from Africa. High rate of discordant serological results/documentation brings up questions regarding the optimal management of IACs, and suggests a rapid, careful, and complete assessment of immunization status timely after IAC’s arrival. Serological testing of IAC of all ages followed by vaccination of seronegative children should be provided.
机译:预防疫苗可预防疾病(VPD)是医疗系统面临的挑战。不同的研究强调了国际收养儿童(IAC)的次优免疫。为了评估大型IAC人群中针对麻疹,腮腺炎,风疹(MMR)和水痘(V)的免疫状况,所有IAC(<18岁)的首次筛查就诊数据均连续转诊至迈耶儿童大学医院(佛罗伦萨,意大利)从2009年到2018年进行了收集和分析。总共有1927名儿童(中位年龄:5.99岁,四分位间距:3.33–8.21)被纳入研究。超过一半的IAC没有针对MMR-V的保护。原产国的疫苗接种文件的可靠性很差,因为尽管有疫苗接种文件证明了先前的疫苗接种,但超过四分之一的血清学检测的IAC并未受到MMR-V的保护。在15至18岁的儿童以及来自非洲的儿童中,这一点更为明显。血清学结果/文献不一致的高比率引发了有关IAC最佳管理的问题,并建议在IAC到达后及时对免疫状况进行快速,仔细和完整的评估。应提供所有年龄的IAC血清学检测,然后接种阴性儿童。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号